Aoxing Pharmaceutical (AXN) Reports Q1 EPS of $0.02

Aoxing Pharmaceutical (NYSE: AXN) reported Q1 EPS of $0.02, versus $0.00 reported last year. Revenue for the quarter came in at $8.75 million, versus $4.57 million reported last year.

For earnings history and earnings-related data on Aoxing Pharmaceutical (AXN) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• H.C. Wainwright Reiterates Buy Rating on Lifeward (LFWD)
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings